Search For "molnupiravir"
SEC recommends emergency use authorization of Covovax, Corbevax vaccines f
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Read More
SEC to take decision on antiviral Covid pill today
Updated : 4 years, 2 months ago IST
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's drug regulator will be meeting today for antiviral pill Molnupiravir recommendations, sources told to ANI.
Read More
US grants emergency use authorization for Merck's COVID-19 pill
Updated : 4 years, 3 months ago IST
Washington [US], December 23 (ANI): The US Food and Drug Administration (FDA) on Thursday said that it has granted an emergency use authorization for Merck's antiviral pill Molnupiravir that is used to treat COVID-19 patients.
Read More
Sri Lanka approves first oral antiviral pill to treat COVID-19
Updated : 4 years, 4 months ago IST
Colombo [Sri Lanka], November 16 (ANI/Xinhua): Sri Lankan government has endorsed the use of Molnupiravir, the first oral antiviral pill to treat patients infected with SARS-CoV-2, the country's health minister said Tuesday.
Read More
Italy to purchase Molnupiravir drug to treat COVID-19
Updated : 4 years, 4 months ago IST
Rome [Italy], November 5 (ANI/Sputnik): Italy will purchase UK-approved antiviral drug molnupiravir for the treatment of COVID-19, Franco Locatelli, coordinator of the Italian Scientific and Technical Committee on Vaccination, said on Friday.
Read More
UK becomes first country to approve antiviral COVID-19 pill
Updated : 4 years, 4 months ago IST
London [UK], November 4 (ANI): The UK has approved antiviral COVID-19 drug Lagevrio (molnupiravir) after it was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 following a stringent review.
Read More
Australia to buy new COVID-19 drug Molnupiravir if regulator approves, say
Updated : 4 years, 5 months ago IST
Canberra [Australia], October 4 (ANI/Sputnik): Australia will purchase 3,00,000 courses of the developmental oral treatment against COVID-19, Molnupiravir, if it is approved by the Therapeutic Goods Administration (TGA), Australian Prime Minister Scott Morrison said on Monday.
Read More
Optimus announces Interim Clinical Results from Phase III Clinical Trials
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients.
Read More
Hetero announces interim clinical results from Phase III clinical trials o
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 9 (ANI): Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from Phase III clinical trials of Molnupiravir in mild Covid-19 patients conducted across multiple COVID-19 dedicated h
Read More
COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupira
Updated : 4 years, 10 months ago IST
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
Read More
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Read More
Drugs manufacturer from Hyderabad on overdrive
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
Read More